Chalfont, St. Giles and Maidstone, England 2/4/08—GE Healthcare has agreed to purchase Whatman for approximately $713 million, or 270 pence per share, in cash (see IBO 1/15/08), a 12% premium over the stock’s February 1 closing price. Whatman supplies laboratory filtration and other sample preparation products for life science and medical applications, including membranes, chromatography […]
Compendia Bioscience received a $2.4 million Small Business Innovation Research Fast Track Award from the National Cancer Institute for the project, “Development of Oncomine Professional as a Platform for Biopharmaceutical Research and Development.”
Next-generation DNA sequencers have advanced genomic research through more accurate, less costly and faster analyses, and enabled the development of novel applications. The technology will now be applied to a coordinated international effort to better understand the extent of human genetic variation and its relation to disease. The National Institutes of Health’s 1000 Genomes Project […]
Palm Springs, CA 1/27/08—Thermo Fisher Scientific has acquired nAscent Biosciences, a supplier of liquid handling consumables for drug discovery screening. NAscent’s PocketTip pipette tip features nanoliter metering and microliter diluting and can be used with a variety of liquid handling systems and handheld pipettors. According to Timo Hilden, vice president and general manager of Thermo […]
Despite a rally on the final trading day of the month triggered by two interest rates cuts and an economic stimulus package from the US government, the Dow Jones Industrial Average, S&P 500 and NASDAQ experienced one of their worst declines in the month of January in years, falling 4.6%, 6.1% and 9.9%, respectively. The […]
: Last month, the Chinese legislature passed a revision of its 1993 Science and Technology (S&T) Progress Law. According to the revised law, China’s overall R&D spending in the public and private sectors should increase steadily each year. Current plans state that China’s R&D spending will account for 2.5% of its GDP by 2020. The […]
As oil prices continue to hover near $100 a barrel and worldwide demand for energy shows no signs of slowing, it is clear that alternative fuel sources are a necessity. One of the most viable—and currently practical—alternative fuel sources is biofuels, including bioethanol and biodiesel, and government programs in the US and abroad are pursuing […]
A European assessment of drug research practices published in Regulatory Toxicology and Pharmacology has found that acute toxicity tests on animals are unnecessary. In Europe, slightly fewer than 500,000 rats and mice are used annually for toxicity testing. The report estimates that approximately 15,000 animals a year could be spared if the acute toxicity test […]
Dendritics SAS appointed Imgenex the exclusive distributor of its monoclonal cell research antibodies in North America and India. Cell Signaling Technologies is offering a noncommercial, royalty-free license to its PhosphoScan Profiling technology and information from its PhosphoSite knowledgebase to academic and nonprofit institutions. Exiqon A/S granted Applied Biosystems a license to its Locked Nucleic Acids […]
East Hills, NY 1/29/08—Pall announced that it has completed its inquiry of the understatement of US federal income tax payments and the provision for income taxes from 1999 through 2006 (see IBO 8/31/07). The company found intercompany balances were due primarily to the sales of products by Pall Netherlands to Medsep, resulting in dividend income […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
